We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

15 hedge funds and large institutions have $1.4M invested in AIM ImmunoTech in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

15% more funds holding

Funds holding: 13 → 15 (+2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

51% less capital invested

Capital invested by funds: $2.85M → $1.4M (-$1.44M)

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$61.2K
2
Citadel Advisors
Citadel Advisors
Florida
+$40.8K
3
BFA
BlackRock Fund Advisors
California
+$6.8K
4
Deutsche Bank
Deutsche Bank
Germany
+$6.8K
5
TSS
Two Sigma Securities
New York
+$6.8K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$13.6K
2
GC
Guggenheim Capital
Illinois
-$7K
3
Goldman Sachs
Goldman Sachs
New York
-$6.8K
4
VKH
Virtu KCG Holdings
New York
-$6.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$463K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$443K -$13.6K -2 -2%
OAM
3
Occidental Asset Management
California
$184K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$149K +$61.2K +9 +35%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$72K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$26K +$40.8K +6 New
Northern Trust
7
Northern Trust
Illinois
$17K – – –
UBS Group
8
UBS Group
Switzerland
$9K – – –
State Street
9
State Street
Massachusetts
$7K – – –
VKH
10
Virtu KCG Holdings
New York
$6K -$6.8K -1 -50%
BA
11
BlackRock Advisors
Delaware
$6K – – –
Deutsche Bank
12
Deutsche Bank
Germany
$6K +$6.8K +1 New
Bank of New York Mellon
13
Bank of New York Mellon
New York
$5K – – –
BFA
14
BlackRock Fund Advisors
California
$3K +$6.8K +1 New
TSS
15
Two Sigma Securities
New York
$3K +$6.8K +1 New
Goldman Sachs
16
Goldman Sachs
New York
$1K -$6.8K -1 Closed
BTS
17
BB&T Securities
Virginia
$1K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$1K – – –
DC
19
Davenport & Co
Virginia
$805 – – –
GC
20
Guggenheim Capital
Illinois
– -$7K -1 Closed

AIM Hedge Fund Activity: Q4 2015 in Review

15 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2015, worth a combined $1.4M — down 51% from $2.85M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new AIM positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $61.2K. The largest seller was Vanguard Group, cutting an estimated $13.6K.

  • 15 institutional investors held AIM ImmunoTech (AIM) as of Q4 2015, up from 13 in Q3 2015.
  • Funds reported $1.4M of AIM ImmunoTech stock for Q4 2015, down 51% quarter-over-quarter.
  • 4 funds opened new AIM ImmunoTech positions in Q4 2015 and 2 closed out, a net change of +2 holders.
  • The largest AIM ImmunoTech buyer in Q4 2015 was Renaissance Technologies, an estimated $61.2K added.
  • The largest AIM ImmunoTech seller in Q4 2015 was Vanguard Group, an estimated $13.6K sold.

Based on aggregated 13F filings for Q4 2015.